Invanz Interactions
There are 46 drugs known to interact with Invanz (ertapenem), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, 30 are moderate, and 2 are minor.
- View all 46 medications that may interact with Invanz
- View Invanz alcohol/food interactions (1)
- View Invanz disease interactions (5)
Most frequently checked interactions
View interaction reports for Invanz (ertapenem) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- clindamycin
- clonidine
- Colace (docusate)
- doxycycline
- fluconazole
- gabapentin
- ibuprofen
- Lasix (furosemide)
- levofloxacin
- levothyroxine
- lisinopril
- metformin
- MiraLAX (polyethylene glycol 3350)
- nitrofurantoin
- Normal Saline Flush (sodium chloride)
- omeprazole
- ondansetron
- oxycodone
- pantoprazole
- potassium chloride
- prednisone
- Synthroid (levothyroxine)
- tramadol
- trazodone
- vancomycin
- Vitamin D3 (cholecalciferol)
Invanz alcohol/food interactions
There is 1 alcohol/food interaction with Invanz (ertapenem).
Invanz disease interactions
There are 5 disease interactions with Invanz (ertapenem) which include:
More about Invanz (ertapenem)
- Invanz consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: carbapenems
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.